Atrial fibrillation (non-valvular) - edoxaban tosylate [ID624]: committee papers
Table of contents
01 Pre-meeting briefing
02 Company submission
03 NICE clarification Letter
04 Company response to the NICE clarification letter
05 Patient group, submissions AntiCoagulation Europe
06 Patient group, submissions Arrhythmia Alliance
07 Patient group submission AF Association
08 Patient group submission CLOT
09 Professional group submission Royal College of Pathologist
10 Professional group submission UKCPA
11 Expert written personal statements Bakhai
12 Clinical declaration - Khan
13 Patient declaration - WOOD
14 Patient expert statement declaration - HILL
15 Evidence Review Group by Liverpool review implementation group
16 Evidence Review report addendum by Liverpool review implementation group
Atrial fibrillation (non-valvular) - edoxaban tosylate [ID624]: committee papers
06 August 2015 (6.42 Mb 55 sec) |
This page was last updated: 04 August 2015